Today Challenge is the only independently owned, exclusively pharmaceutical printer to accomplish "critical mass". This combination of laser-like focus and wide market reach has fueled our dramatic growth and has helped us become the de facto choice of pharmaceutical manufacturers.
Our responsiveness to customers' needs is enhanced through the use of a secure, electronic network, which connects our facilities and delivers valuable feedback from the manufacturing floor on a real-time basis.
Through the formation of an Urgent Response Team (URT), we are able to complete new product launches for our customers within 24 hours or less.
Our approach to Quality is simple: doing it right the first time, every time. Our Quality Group is a separate entity, with an independent reporting structure.
As part of our strategic product portfolio diversification plan, our latest round of capital investments includes the acquisition of specialized, high speed assembly equipment for the production of Extended Content Labeling (ECL) for pharmaceutical and other applications.
As opposed to simply m